This inventor holds 6 USPTO granted patents and 6 published patent applications and 1 EPO patent. Top assignee: Immunogen, Inc.. Active years: 2019-2023.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2019-2023
Title: The Innovations of Benjamin M. Hutchins: A Pioneer in Antibody Drug Conjugates
Introduction
Benjamin M. Hutchins is an accomplished inventor based in Boxborough, Massachusetts, with a noteworthy contribution to the field of biotechnology. He holds six patents, reflecting a strong focus on creating novel methods for the development of impactful medical applications.
Latest Patents
Among his latest patents are two significant inventions. The first, titled "Selective sulfonation of benzodiazepine derivatives," introduces innovative methods for preparing cell-binding agent-cytotoxic agent conjugates. This invention emphasizes the use of engineered cysteine residues to enhance the efficacy of these conjugates in inhibiting abnormal cell growth or treating proliferative disorders in mammals. The second patent, "Methods for antibody drug conjugation, purification, and formulation," outlines a range of techniques that optimize the production and quality of antibody drug conjugates (ADCs). By employing continuous conjugation processes and advanced filtration technologies, these methods not only reduce processing times and costs but also improve consistency in the final products.
Career Highlights
Hutchins currently works at Immunogen, Inc., a leading biotechnology company focused on developing innovative ADCs for cancer treatment. His role within the organization allows him to leverage his expertise in the creation and refinement of therapeutic agents that have the potential to make a significant impact on patient outcomes.
Collaborations
Throughout his career, Hutchins has collaborated with esteemed colleagues, including Scott A. Hilderbrand and Daniel F. Milano. Together, they have contributed to advancing the field of antibody-drug conjugation and improving methodologies that support the production of next-generation therapeutic agents.
Conclusion
Benjamin M. Hutchins is a prominent figure in the realm of biotechnology and drug development. His dedication to researching and patenting innovative methodologies for antibody drug conjugates highlights his commitment to enhancing therapeutic options for patients. As the landscape of medicine continues to evolve, inventors like Hutchins play a crucial role in driving advancements that can lead to groundbreaking treatments.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile